Brain Health Supplements Market is expected to reach US$ 14,249.5 Million by 2028

The global brain health supplements market is expected to reach at US$ 14,249.53 million by 2028. registring at a CAGR of 11.7% from 2022 to 2028, according to a new research study conducted by The Insight Partners.

Natural Molecules Segment to Lead Brain Health Supplements Market During 2022–2028

According to our latest study on "Brain Health Supplements Market Forecast to 2028 – COVID-19 Impact and Global Analysis – by Product, Application, Dosage Form, Distribution Channel, and Age Category," the market is expected to grow from US$ 6,634.3 million in 2021 to US$ 14,249.5 million by 2028; it is estimated to grow at a CAGR of 11.7% from 2022 to 2028.

The report highlights the key factors driving the market and prominent players with their developments. The growing prevalence of major depressive disorders and increasing demand for brain supplements among the elderly population primarily boost the market growth. However, the lack of regulations and false claims by manufacturers hinder the growth of the brain health supplements market.

Depression, which is a common mental disorder, is different from normal mood fluctuations and temporary emotional responses to challenges faced every day. When depression is recurrent with moderate or severe intensity, it may become a severe health issue. It can hamper the performance of affected individuals in homes, workplaces, schools, etc. People suffering from depression are also likely to attempt suicide. According to estimates by the World Health Organization (WHO), 5% of adults (~280 million) suffer from depression globally. Further, according to the National Institute of Mental Health (NIMH), in the US, ~14.8 million adults aged 18 and above (i.e., 6.0% of the total adult population) had at least one major depressive episode with serious impairment in 2020.

Brain Health Supplements Market, by Region, 2021 (%)

Cases of chronic depression are increasing in Europe. According to Eurostat, in 2019, 7.2% of European Union (EU) citizens had chronic depression. In European Union (EU), 12.2% of people in Portugal reported having chronic depression in 2019, followed by Sweden (11.7%), and Germany and Croatia (11.6% both). Per the data published by KPMG International, the prevalence of depression is higher in Asia Pacific compared to the rest of the world, especially in the younger population. According to the National Center for Biotechnology Information (NCBI), there is growing evidence about the role of nutrients in mental health. The adequate consumption of nutrients contributes to better overall health and mental health. Hence, the optimum supply of nutrients as adjunctive therapy to antidepressants is essential for adequate brain functioning. Thus, the growing prevalence of major depressive disorders is driving the growth of the brain health supplements market.

Based on product, the brain health supplements market is segmented into natural molecules, herbal extracts, and vitamins & minerals. The natural molecules segment held the largest share of the market in 2021, and it is also expected to record rapid growth during the forecast period. According to a report by the Uniformed Services University, brain health supplements are mostly natural or herbal nootropics (smart drugs and cognitive enhancers, similar to adaptogens) that include ingredients such as ashwagandha, Bacopa monnieri, Ginkgo biloba, ginseng, huperzine A, omega-3 fatty acids, rhodiola, and valerian. Natural molecules are increasingly being used as supplements as no or negligible side effects are associated with them. Further, nootropic supplement ingredients such as higenamine, sulbutiamine, and hordenine are approved by the US Food and Drug Administration (FDA) under the "Dietary Supplement Ingredient Advisory List" based on the preliminary evaluation for the ingredients not appearing to be lawfully included and sold under dietary supplement products.

Health Via Modern Nutrition Inc. (HVMN Inc.); Unilever PLC; Quincy Bioscience; Peak Nootropics; Danone SA; Harbin Pharmaceutical Group Co.; Purelife bioscience Co., Ltd; Procera Health; Natural Factors; and LIQUID HEALTH, INC. are among the leading companies operating in the brain health supplements market.

The report segments the brain health supplements market as follows:

Based on product, the brain health supplements market is segmented into natural molecules, herbal extracts, and vitamins & minerals. In terms of application, the market is segmented into memory enhancement, attention & focus, depression & mood, sleep & recovery, antiaging & longevity, and others. The brain health supplements market, by dosage form, is segmented into tablets, capsules, and others. Based on distribution channel, the brain health supplements market is segmented into supermarket & hypermarket, drug store, online, and others. In terms of age category, the market is segmented into adults, children, and elderly. By geography, the brain health supplements market is segmented into North America (US, Canada, and Mexico), Europe (UK, Germany, France, Italy, Spain, and Rest of Europe), Asia Pacific (China, Japan, India, Australia, South Korea, and Rest of Asia Pacific), the Middle East & Africa (UAE, Saudi Arabia, South Africa, and Rest of Middle East & Africa), and South & Central America (Brazil, Argentina, and Rest of South & Central America).

Contact Us
 
Phone: +1-646-491-9876
Email Id: sales@theinsightpartners.com